TransTech Pharma.

PositionTriad - Finance - Brief Article

HIGH POINT -- TransTech Pharma got $10 million in venture-capital financing in July and expects $20 million more by early 2005. New York venture firm MacAndrews & Forbes Holdings is the current round's primary investor. TransTech Pharma, which has attracted $100 million...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT